Table: Garna Biosciences -Q1 group results

Carna Biosciences

10/05/2024 07:30

May 10 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Mar 31, 2024        Mar 31, 2023       Dec 31, 2024  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales            180 mln             226 mln           925 mln     
                 (-20.3 pct)         (-59.1 pct)       (-43.0 pct)   
  Operating     loss 416 mln        loss 505 mln        loss 2.20    
  Recurring     loss 394 mln        loss 513 mln        loss 2.21    
  Net                                                   loss 2.23    
  Net           loss 398 mln        loss 519 mln                     
  EPS          loss 23.27 yen      loss 32.78 yen    loss 129.81 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T